Treatment of influenza A & B in adults and children aged 1 /year and above, when started within 48 /hours of symptom onset /
Post exposure prophylaxis in those aged ≥1 /year (treatment) or ≥13 /years (preventive use), during confirmed exposure to influenza
Dosage (Adults & Adolescents ≥13 /years):
Treatment: 75 /mg twice daily for 5 days.
Prevention: 75 /mg once daily for 10 days (or up to 6 weeks during outbreaks)
Administration:
Swallow capsule whole with water, with or without food.
For those unable to swallow capsules, open and mix powder with ≤1 teaspoon of sweet food or in an oral syringe with water, then administer immediately
Timing:
Initiate treatment as soon as possible, within 48 /hours of symptom onset.
If used for prophylaxis, begin within 48 /hours of exposure
Dose Adjustment:
Reduce dose or frequency in patients with renal impairment (CrCl ≤60 /ml/min) or undergoing dialysis
Storage: Keep capsules below 30 /°C in a cool, dry place
Malaysia